z-logo
open-access-imgOpen Access
Potential role of hypovitaminosis D and vitamin D supplementation during COVID-19 pandemic
Author(s) -
Monica Verdoia,
Giuseppe De Luca
Publication year - 2020
Publication title -
qjm
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 118
eISSN - 1460-2725
pISSN - 1460-2393
DOI - 10.1093/qjmed/hcaa234
Subject(s) - vitamin d and neurology , hypovitaminosis , pandemic , covid-19 , vitamin d deficiency , medicine , virology , disease , outbreak , infectious disease (medical specialty)
Summary Vitamin D deficiency is a pandemic disorder affecting over 1 billion of subjects worldwide and displaying a broad spectrum of implications on cardiovascular and inflammatory disorders. Since the initial reports of the association between hypovitaminosis D and COVID-19, Vitamin D has been pointed as a potentially interesting treatment for SARS-CoV-2 infection. We provide an overview on the current status of vitamin D deficiency, the mechanisms of action of vitamin D and the current literature on the topic, with a special focus on the potential implications for COVID-19 pandemic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom